Delivery Order SPE2DB20D2002-SPE2DB23FL10Y
- Not listed
- This federal contract award, valued at $85,532.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for the VARIVAX vaccine with diluents, a critical medical commodity for defense and veterans' healthcare programs. The contract has a firm fixed price and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $11,380.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the VARIVAX Vaccine with Diluents, with a completion date of July 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $1,874.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VARIVAX vaccine with diluents and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will be fulfilling the order. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VARIVAX vaccine with diluents. The $66,820.80 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $94,114.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, a pharmaceutical product used for vaccination purposes. The award has an ultimate completion date of June 13, 2023 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,057.80 delivery order contract is for the provision of VARIVAX vaccine with diluents. The contract has a firm fixed price and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of VARIVAX vaccine with diluents. The contract, valued at $39,994.60, is a Firm Fixed Price Delivery Order with a completion date of February 22, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award, valued at $8,603.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VARIVAX vaccine with diluents. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award is a delivery order (SPE2DB23FL46M) valued at $3,764.56, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VARIVAX vaccine with diluents. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen name. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- The federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $74,207.40, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is July 29, 2022. The contract does not have a set-aside designation,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL10YDelivery Order
This federal contract award, valued at $47,387.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of VARIVAX vaccine with diluents. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.4k | 1/6/23 |